অস্ট্রিয়া -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
জার্মানি -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
ফ্রান্স -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
আয়ার্লণ্ড -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
ইতালী -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
নেদারল্যান্ডস -
ইংরেজি -
HMA (Heads of Medicines Agencies)
prascend 1mg tablets for horses
boehringer ingelheim vetmedica gmbh - pergolide mesilate 1.31 mg - tablet - horses non food - pergolide
ইস্রায়েল -
ইংরেজি -
Ministry of Health
azilect
teva israel ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
ইস্রায়েল -
ইংরেজি -
Ministry of Health
azilect
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
ইস্রায়েল -
ইংরেজি -
Ministry of Health
azilect
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
ইস্রায়েল -
ইংরেজি -
Ministry of Health
comtan
novartis israel ltd - entacapone - film coated tablets - entacapone 200 mg - entacapone - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.